Therasis Raises $12 Million
Therasis Inc., a New York-based oncology drug discovery startup, has raised $12 million in Series A funding from Tilocor Life Science.
8 December 2009•3 mins read
Therasis Inc., a New York-based oncology drug discovery startup, has raised $12 million in Series A funding from Tilocor Life Science.
